文献速递产科麻醉区域麻醉与超声术前评估与围术期医学

干预措施预防或治疗硬膜外相关产热:系统综述与荟萃分析

Interventions for the prevention or treatment of epidural-related maternal fever: a systematic review and meta-analysis.
PubMed 文献 · Br J Anaesth · 2022-08-05

该系统综述与荟萃分析纳入34项RCT,评估预防或治疗硬膜外相关产热的干预措施。主要结局为产时发热发生率。降低硬膜外剂量在剔除高偏倚风险试验后未显著降低产时发热(7项试验;857例;RR=0.83;95%CI 0.41-1.67)。替代镇痛方法与高剂量预防性全身类固醇较硬膜外镇痛降低产时发热风险,预防性对乙酰氨基酚无效。无明确证据支持任一单独干预措施。

要点

  • 降低硬膜外剂量在剔除高偏倚风险试验后未显著降低产时发热。
  • 替代镇痛方法与高剂量预防性全身类固醇较硬膜外镇痛降低产时发热风险。
  • 预防性对乙酰氨基酚对硬膜外相关产热无效。

核心结论

  • 无明确证据支持任何单独预防或治疗干预措施用于硬膜外相关产热。
  • 进一步研究应聚焦发热发生机制以开展潜在干预的RCT。

研究设计与样本

  • 系统综述与荟萃分析,纳入34项RCT(42条记录),评估活动期产程中预防或治疗硬膜外相关产热的干预措施。
  • 检索MEDLINE、EMBASE、CINAHL、Web of Science、CENTRAL及灰色文献,从建库至2021年4月。
  • 使用Cochrane RoB 2工具评估偏倚风险,主要结局产时发热发生率采用DerSimonian and Laird随机效应模型汇总RR及95%CI。

主要发现

  • 降低硬膜外剂量在剔除6项高偏倚风险试验后未显著降低产时发热(7项试验;857例;RR=0.83;95%CI 0.41-1.67)。
  • 替代镇痛方法与高剂量预防性全身类固醇较硬膜外镇痛降低产时发热风险。
  • 预防性对乙酰氨基酚无效。

临床怎么用

  • 目前无明确证据支持常规使用任一单独干预措施预防或治疗硬膜外相关产热。
  • 替代镇痛方法与高剂量预防性全身类固醇显示降低产时发热风险,但需结合具体临床情境评估。
  • 预防性对乙酰氨基酚不推荐用于该目的。

局限性

  • 部分合并分析在剔除高偏倚风险试验后失去统计学显著性。
  • 发热发生机制尚不明确,限制针对性干预的RCT设计。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Epidural-related maternal fever in women in labour has consequences for the mother and neonate. There has been no systematic review of preventive strategies. METHODS: RCTs evaluating methods of preventing or treating epidural-related maternal fever in women in active labour were eligible. We searched MEDLINE, EMBASE, CINAHL, Web of Science, CENTRAL, and grey literature sources were searched from inception to April 2021. Two review authors independently undertook study selection. Data extraction and quality assessment was performed by a single author and checked by a second. The Cochrane Risk of Bias 2 tool was used. Meta-analyses for the primary outcome, incidence of intrapartum fever, were performed using the DerSimonian and Laird random effects model to produce summary risk ratios (RRs) with 95% confidence intervals (95% CIs). RESULTS: Forty-two records, representing 34 studies, were included. Methods of reduced dose epidural reduced the incidence of intrapartum fever, but this was not statistically significant when six trials at high risk of bias were removed (seven trials; 857 participants; RR=0.83; 95% CI, 0.41-1.67). Alternative methods of analgesia and high-dose prophylactic systemic steroids reduced the risk of intrapartum fever compared with epidural analgesia. Prophylactic paracetamol was not effective. CONCLUSIONS: There is no clear evidence to support the use of any individual preventative or therapeutic intervention for epidural-related maternal fever. Further research should focus on understanding the mechanism of fever development to enable RCTs of potential interventions to reduce the incidence of intrapartum fever development and the subsequent disease burden felt by the neonate. CLINICAL TRIAL REGISTRATION: CRD42021246929.

来源:Br J Anaesth,查看原文。版权归原作者所有。

引用

  1. Cartledge A, Hind D, Bradburn M, et al. Interventions for the prevention or treatment of epidural-related maternal fever: a systematic review and meta-analysis. Br J Anaesth. 2022. PMID: 35934529. doi:10.1016/j.bja.2022.06.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。